Xiamen Amoytop Biotech Co Ltd
SSE:688278
Xiamen Amoytop Biotech Co Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
47.1
86.17
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Xiamen Amoytop Biotech Co Ltd hold over its rivals?
What risks and challenges
does Xiamen Amoytop Biotech Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Xiamen Amoytop Biotech Co Ltd.
Provide an overview of the primary business activities
of Xiamen Amoytop Biotech Co Ltd.
What unique competitive advantages
does Xiamen Amoytop Biotech Co Ltd hold over its rivals?
What risks and challenges
does Xiamen Amoytop Biotech Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Xiamen Amoytop Biotech Co Ltd.
Provide P/S
for Xiamen Amoytop Biotech Co Ltd.
Provide P/E
for Xiamen Amoytop Biotech Co Ltd.
Provide P/OCF
for Xiamen Amoytop Biotech Co Ltd.
Provide P/FCFE
for Xiamen Amoytop Biotech Co Ltd.
Provide P/B
for Xiamen Amoytop Biotech Co Ltd.
Provide EV/S
for Xiamen Amoytop Biotech Co Ltd.
Provide EV/GP
for Xiamen Amoytop Biotech Co Ltd.
Provide EV/EBITDA
for Xiamen Amoytop Biotech Co Ltd.
Provide EV/EBIT
for Xiamen Amoytop Biotech Co Ltd.
Provide EV/OCF
for Xiamen Amoytop Biotech Co Ltd.
Provide EV/FCFF
for Xiamen Amoytop Biotech Co Ltd.
Provide EV/IC
for Xiamen Amoytop Biotech Co Ltd.
Show me price targets
for Xiamen Amoytop Biotech Co Ltd made by professional analysts.
What are the Revenue projections
for Xiamen Amoytop Biotech Co Ltd?
How accurate were the past Revenue estimates
for Xiamen Amoytop Biotech Co Ltd?
What are the Net Income projections
for Xiamen Amoytop Biotech Co Ltd?
How accurate were the past Net Income estimates
for Xiamen Amoytop Biotech Co Ltd?
What are the EPS projections
for Xiamen Amoytop Biotech Co Ltd?
How accurate were the past EPS estimates
for Xiamen Amoytop Biotech Co Ltd?
What are the EBIT projections
for Xiamen Amoytop Biotech Co Ltd?
How accurate were the past EBIT estimates
for Xiamen Amoytop Biotech Co Ltd?
Compare the revenue forecasts
for Xiamen Amoytop Biotech Co Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Xiamen Amoytop Biotech Co Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Xiamen Amoytop Biotech Co Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Xiamen Amoytop Biotech Co Ltd compared to its peers.
Compare the P/E ratios
of Xiamen Amoytop Biotech Co Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Xiamen Amoytop Biotech Co Ltd with its peers.
Analyze the financial leverage
of Xiamen Amoytop Biotech Co Ltd compared to its main competitors.
Show all profitability ratios
for Xiamen Amoytop Biotech Co Ltd.
Provide ROE
for Xiamen Amoytop Biotech Co Ltd.
Provide ROA
for Xiamen Amoytop Biotech Co Ltd.
Provide ROIC
for Xiamen Amoytop Biotech Co Ltd.
Provide ROCE
for Xiamen Amoytop Biotech Co Ltd.
Provide Gross Margin
for Xiamen Amoytop Biotech Co Ltd.
Provide Operating Margin
for Xiamen Amoytop Biotech Co Ltd.
Provide Net Margin
for Xiamen Amoytop Biotech Co Ltd.
Provide FCF Margin
for Xiamen Amoytop Biotech Co Ltd.
Show all solvency ratios
for Xiamen Amoytop Biotech Co Ltd.
Provide D/E Ratio
for Xiamen Amoytop Biotech Co Ltd.
Provide D/A Ratio
for Xiamen Amoytop Biotech Co Ltd.
Provide Interest Coverage Ratio
for Xiamen Amoytop Biotech Co Ltd.
Provide Altman Z-Score Ratio
for Xiamen Amoytop Biotech Co Ltd.
Provide Quick Ratio
for Xiamen Amoytop Biotech Co Ltd.
Provide Current Ratio
for Xiamen Amoytop Biotech Co Ltd.
Provide Cash Ratio
for Xiamen Amoytop Biotech Co Ltd.
What is the historical Revenue growth
over the last 5 years for Xiamen Amoytop Biotech Co Ltd?
What is the historical Net Income growth
over the last 5 years for Xiamen Amoytop Biotech Co Ltd?
What is the current Free Cash Flow
of Xiamen Amoytop Biotech Co Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Xiamen Amoytop Biotech Co Ltd.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
CN |
X
|
Xiamen Amoytop Biotech Co Ltd
SSE:688278
|
31.4B CNY | 30.4 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | -201 430.7 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
328.6B USD | 15.1 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
154.6B USD | 14.1 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
135.2B USD | 9.9 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.3B USD | 24.5 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | -560.9 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
120B AUD | 17.4 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
53.7B USD | 10.5 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | -64.2 |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.6B USD | -657 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
CN |
X
|
Xiamen Amoytop Biotech Co Ltd
SSE:688278
|
Average EV/EBITDA:
17.4
30.4
|
32%
|
1 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
Negative Multiple: -201 430.7 | N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
15.1
|
13%
|
1.2 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
14.1
|
17%
|
0.8 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
9.9
|
6%
|
1.6 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
24.5
|
17%
|
1.4 |
|
US |
E
|
Epizyme Inc
F:EPE
|
Negative Multiple: -560.9 | N/A | N/A |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
17.4
|
11%
|
1.6 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
10.5
|
11%
|
1 |
|
US |
S
|
Seagen Inc
F:SGT
|
Negative Multiple: -64.2 | N/A | N/A |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
Negative Multiple: -657 | N/A | N/A |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.